Testicular cancer
Conditions
Interventions
Gold Standard:Postoperative pathology of pcRPLND
Index test:CT-based radiomics combined with serum miRNA
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1: Primary testicular or retroperitoneal germ cell tumor 2: Imaging stage II or III before chemotherapy 3: Received first-line platinum-based chemotherapy 4: Scheduled for retroperitoneal lymph node dissection after chemotherapy
Exclusion criteria
Exclusion criteria: 1: The primary tumor of the testis is a pure seminoma 2: Patients with a pathological diagnosis of coexisting malignancies 3: Patients who have not undergone first-line chemotherapy for testicular cancer or who have not completed the planned chemotherapy due to adverse reactions or other reasons 4: Elevated tumor markers following chemotherapy 5: Residual retroperitoneal mass with a maximum diameter less than 1 cm after chemotherapy 6: Missing clinical and pathological data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Macro-average area under the receiver operating characteristic curve,macroAUC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy;Precision;Specificity;Sensitivity;F1 score; | — |
Countries
China
Contacts
Public ContactZhuowei Liu
Sun Yat-sen University Cancer Center
Outcome results
None listed